NUWE Key Statistics, Chart & Performance
The current stock price of NUWE is 2.255 USD. In the past month the price decreased by -18.41%. In the past year, price decreased by -95.76%.
NUWE Latest News, Press Relases and Analysis
NUWE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.31 | 219.65B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.94 | 201.26B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.57 | 146.79B | ||
| SYK | STRYKER CORP | 27.84 | 140.23B | ||
| IDXX | IDEXX LABORATORIES INC | 58.11 | 58.51B | ||
| BDX | BECTON DICKINSON AND CO | 13.21 | 54.59B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.96 | 49.16B | ||
| RMD | RESMED INC | 25.34 | 36.62B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.48 | 36.54B | ||
| DXCM | DEXCOM INC | 34.65 | 25.14B | ||
| PODD | INSULET CORP | 67.61 | 21.74B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.64 | 18.66B |
Related stock screener links
About NUWE
Company Profile
Nuwellis, Inc. operates as a medical device company. The company is headquartered in Eden Prairie, Minnesota and currently employs 38 full-time employees. The company went IPO on 2012-02-16. The firm is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Company Info
NUWELLIS INC
12988 Valley View Rd
Eden Prairie MINNESOTA 55344 US
CEO: Nestor Jaramillo
Employees: 38
Phone: 19523454200
NUWELLIS INC / NUWE FAQ
Can you describe the business of NUWELLIS INC?
Nuwellis, Inc. operates as a medical device company. The company is headquartered in Eden Prairie, Minnesota and currently employs 38 full-time employees. The company went IPO on 2012-02-16. The firm is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
What is the current price of NUWE stock?
The current stock price of NUWE is 2.255 USD. The price decreased by -6.04% in the last trading session.
Does NUWELLIS INC pay dividends?
NUWE does not pay a dividend.
How is the ChartMill rating for NUWELLIS INC?
NUWE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
On which exchange is NUWE stock listed?
NUWE stock is listed on the Nasdaq exchange.
Can you provide the number of employees for NUWELLIS INC?
NUWELLIS INC (NUWE) currently has 38 employees.
When does NUWELLIS INC (NUWE) report earnings?
NUWELLIS INC (NUWE) will report earnings on 2026-03-09, after the market close.
NUWE Technical Analysis
NUWE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NUWE. Both the profitability and financial health of NUWE have multiple concerns.
NUWE Financial Highlights
Over the last trailing twelve months NUWE reported a non-GAAP Earnings per Share(EPS) of -769.02. The EPS decreased by -71.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -159.51% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NUWE Forecast & Estimates
For the next year, analysts expect an EPS growth of 99.74% and a revenue growth 2.8% for NUWE